#TCRs
I’m waiting for the skinny-tired turbocharged TCRs next. Hope they have their catchers’ mitts at the marshal posts.
November 20, 2026 at 2:56 AM
Multiple Sclerosis Relapses Are Associated With EBV-Specific T-Cell Expansion Amid Broad Immune Activation.
Neurol Neuroimmunol Neuroinflamm

This week in Multiple Sclerosis and Neuroimmunology: palamedesreport.org/this-week/multiple-sclerosis

#MedSky #neurology #multiplesclerosis
November 19, 2026 at 2:00 PM
Instead, we found that #TCRs from splenic Ly49+ CD8 Tregs deterministically direct natural IEL development.
November 14, 2026 at 1:18 PM
Overnight this ICE flight landed in Sierra Leone, then went to its layover in Senegal.

This is a possible third-country removal, though not all removals to SL are TCRs. (The Sept 2 removal, for example, was only nationals, per a passenger onboard.)
Another private jet ICE flight to Africa in progress.
November 12, 2026 at 2:07 PM
We are glad to report a #preprint from our lab in which we show #TCRs from #CD8Tregs direct the #development of natural #IELs. This work is done by a talentd student in our lab -Sam Murphy www.biorxiv.org/content/10.6...
T cell receptors from CD8 regulatory T cells direct the development of natural intraepithelial lymphocytes
CD8 regulatory T cells (CD8 Tregs) in mice have been identified by their expression of the surface receptor family Ly49 and the transcription factor Helios. To our surprise, many Ly49+ and Helios+ T c...
www.biorxiv.org
November 14, 2026 at 1:18 PM
Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession
Defining the dynamics of T cell memory formation with epitope-level resolution can inform vaccine design. Longitudinal T cell receptor (TCR) sequencing after COVID-19 mRNA vaccination has enabled detailed tracking of T cell responses; however, connecting expanded clonotypes following antigen exposure to their cognate epitopes remains a challenge due to limited curated paired α/βTCR information. To fill this gap, we used TIRTL-seq to identify paired α/βTCRs from CD8+ T cell lineages associated with mRNA immunization in serial samples across 38 healthy donors over multiple rounds of vaccinations. Vaccine-associated paired α/βTCRs, identified based on their longitudinal kinetics, were grouped according to sequence similarity to infer their shared epitope specificities. We assigned epitope specificity to 1,109 clonotypes, recognizing 15 SARS-CoV-2 spike targets, identifying multiple previously undescribed responses, and confirming putative specificities experimentally. This approach uncovered a striking pattern of clonal succession in anti-spike T cell memory lineages resulting from repeated vaccination, characterized by a transition from low-avidity clones recognizing conserved coronavirus epitopes to high-avidity clones targeting epitopes unique to SARS-CoV-2. These results highlight the surprisingly dynamic responses underlying homologous boosting, suggest avenues for improving vaccine strategies, and pave the way for repertoire-based monitoring of antigen-specific T cell immunity. ### Competing Interest Statement P.G.T. is on the Scientific Advisory Board of Immunoscape and Shennon Bio, has received research support and personal fees from Elevate Bio, and consulted for 10X Genomics, Illumina, Pfizer, Cytoagents, Sanofi, Merck, and JNJ. P.G.T., M.V.P., and A.A.M. have patents related to TCR amplification, cloning and/or applications thereof. P.X. is currently a full-time employee of ImmunoGeneTeqs, Inc. T.I. reports research funding from Rohto Pharmaceutical Co., Ltd and Biometrics Sympathies Inc. K.M. reports stock for ImmunoGeneTeqs, Inc. S.U. reports an advisory role for ImmunoGeneTeqs, Inc. and stock for ImmunoGeneTeqs, Inc. The other authors declare no competing interests. National Institutes of Health, https://ror.org/01cwqze88, R01 AI136514, U19 AI181103, P01 AI165077, R35 GM141457 St. Jude Center for Influenza Research and Response (SJCEIRR), 75N93021C0016 Center for Influenza Vaccine Research in High Risk Populations (CIVR-HRP), 75N93019C00052 Cancer Research Institute Irvington Postdoctoral Fellowship, CRI14316 Japan Agency for Medical Research and Development, https://ror.org/004rtk039, JP256f0137011, JP22fk0310509, JP25fk0310531, JP26ck0106121 Japan Society for the Promotion of Science, https://ror.org/00hhkn466, JPJS00420240025, JP23K27397, JP26K02239
www.biorxiv.org
November 15, 2026 at 4:20 PM
This aircraft has done ICE charter flights to: Albania, Armenia, Bosnia, Eswatini, Ghana (five times), Guinea, Kenya, Latvia, Liberia (twice), Moldova, Nigeria, and Tanzania.

Eswatini and Moldova were confirmed third-country removals. Ghana, Kenya, and Liberia landings may have also been TCRs.
November 9, 2026 at 4:50 AM
I don't recall ever seeing an article about it other than your excellent coverage. It's like TCRs don't exist.

But they do.
November 9, 2026 at 5:38 PM
Public TCRs can recur through convergent recombination, not only shared antigen recognition. Functional testing across HLA backgrounds and prospective tumour cohorts is crucial—especially for the nine novel families—to separate true specificity from generation probability and cohort structure.
November 10, 2026 at 12:01 AM
i would rather just tcrs for fwd
November 5, 2026 at 11:22 PM
T-Therapeutics raised $133M for cancer and autoimmune TCRs, adding J&J, Merck KGaA and Lilly as backers.
T-Therapeutics secures $133M for cancer, autoimmune TCRs
J&J, Merck KGaA & Eli Lilly join Sanofi in T-Therapeutics' $133M Series B to advance TCR therapies for cancer & autoimmune conditions into clinic.
endpoints.news
November 5, 2026 at 1:22 PM
November 5, 2026 at 10:36 AM
——— 𝐒𝐄 𝐁𝐔𝐒𝐂𝐀

ɴ𝑜mʙʀᴇ : ɢʀᴀɴᴛ mᴀʀʟ𝑜ɯᴇ.
ᴇᴅᴀᴅ : 30 ᴀɴ̃𝑜𝑠.
𝑜𝑐ᴜᴘᴀ𝑐ɪ𝑜́ɴ : 𝑐𝑜ɴᴛᴀᴅ𝑜ʀ.
𝑓𝑐 𝑠ᴜɢᴇʀɪᴅ𝑜 : ɢᴇ𝑜ʀɢᴇ mᴀ𝑐ᴋᴀʏ.

ᴘᴀʀᴀ 𝑜ᴛᴘ @tcrsonmypiano.bsky.social
November 5, 2026 at 10:35 AM
𝑠ᴇ ʙᴜ𝑠𝑐ᴀ : m𝑎𝑡𝑡ℎ𝑒ɯ m𝑜𝑟𝑟𝑖𝑔𝑎n.
ᴇᴅᴀᴅ : 35 𝑎ñ𝑜𝑠.
𝑜𝑐ᴜᴘᴀ𝑐ɪ𝑜́ɴ : ᴛ𝑒́𝑐n𝑖𝑐𝑜 𝑒𝑙𝑒𝑐𝑡𝑟𝑜́n𝑖𝑐𝑜.
𝑓𝑐 𝑠ᴜɢᴇʀɪᴅ𝑜 : ɢ𝑙𝑒n ᴘ𝑜ɯ𝑒𝑙𝑙.
November 5, 2026 at 10:35 AM
Molecular and clinical data for 150,000 solid cancer cases helped researchers identify shared T-cell receptors with potential activity against several known cancer antigens.
Tumor Sequence Analyses Unearth Shared TCRs With Potential Activity Against Cancer Antigens
Tumor Sequence Analyses Unearth Shared TCRs With Potential Activity Against Cancer Antigens
ebx.sh
November 6, 2026 at 1:04 AM
Home students, our lab would qualify for the newly minted Sir John Gurdon PhD Studentships in Developmental Biology. In case you are interested get in touch via direct message or email please. www.jobs.cam.ac.uk/job/57626/
Sir John Gurdon-TCRS PhD Studentships in Developmental Biology - Job Opportunities - University of Cambridge
Sir John Gurdon-TCRS PhD Studentships in Developmental Biology in the Gurdon Institute at the University of Cambridge.
www.jobs.cam.ac.uk
November 4, 2026 at 5:20 PM
In a phase 1/2 clinical trial in patients with ICB-resistant, antigen-rich solid tumors, Sullivan, Tschernia, Friedman, et al. evaluated invika – IL-2 fused to a bispecific antibody targeting Vβ6 and Vβ10 TCRs.
bit.ly/3VaNpj7
@mgbresearch.bsky.social
@mskcancercenter.bsky.social
November 5, 2026 at 4:45 PM
General prediction of T cell receptor antigen specificity from sequence using AlphaFold 3
Science Advances
www.science.org/doi/10.1126/...
General prediction of T cell receptor antigen specificity from sequence using AlphaFold 3
The major histocompatibility complex (MHC):peptide:T cell receptor (TCR) complex is the most diverse trimolecular interface known in nature and a key trigger for adaptive immunity. TCRs are now routin...
www.science.org
November 3, 2026 at 2:34 AM